CRBU
Caribou Biosciences, Inc. (CRBU)
NASDAQ · Healthcare
Caribou Biosciences, Inc. annual/quarterly total liabilities history from 2020 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Caribou Biosciences, Inc. total liabilities for the quarter ending December 31, 2025 were 53.2M, a 11.88% decrease year-over-year.
- Caribou Biosciences, Inc. total liabilities for 2025 were 53.2M, a 11.88% decrease from 2024.
- Caribou Biosciences, Inc. total liabilities for 2024 were 60.4M, a 5.40% decrease from 2023.
- Caribou Biosciences, Inc. total liabilities for 2023 were 63.8M, a 12.46% decrease from 2022.
- Caribou Biosciences, Inc. total liabilities for 2022 were 72.9M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Caribou Biosciences, Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $53 |
| 2024 | $60 |
| 2023 | $64 |
| 2022 | $73 |
| 2021 | $55 |
| 2020 | $18 |
| Caribou Biosciences, Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $53 |
| 2024-12-31 | $60 |
| 2023-12-31 | $64 |
| 2022-12-31 | $73 |
| 2021-12-31 | $55 |
| 2020-12-31 | $18 |
Caribou Biosciences, Inc. Total Liabilities — FAQ
Caribou Biosciences, Inc. (CRBU) total liabilities over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CRBU's total liabilities history?
The chart and table above show Caribou Biosciences, Inc.'s total liabilities by year and by quarter, including the growth rate.